Abstract
Background
Roux-en-Y gastric bypass (RYGB) is one of the most frequently performed bariatric procedures worldwide. Remnant gastric cancer after RYGB is a rare complication. There were about seventeen cases reported in the world. The location of the tumor in these cases occurs mainly in the gastric antrum, followed by the body, then the pylorus and linitis plastica, and the last was fundus of the stomach. To the best of our knowledge, this is the first case that gastric cancer located in the cardia of stomach after RYGB.
Case Report
A 68-year-old male patient had chronic esophagitis, bile reflux gastritis, and erosive antral gastritis 5 years after RYGB and now developed to aggressive carcinoma in the gastric pouch. In spite of having chemotherapy and traditional Chinese medicine therapy, the patient died of multiple organ failure after 15 months.
Conclusions
This case report highlights the importance to have gastroscopy to observe the proximal small remnant stomach after RYGB in long-term follow-up. Attention must be paid when patients develop symptoms like abdominal pain or excessive weight loss after RYGB. For patients at high risk such as those who have a family history of gastric cancer or presenting abnormal levels of tumor markers should rather undergo Sleeve Gastrectomy plus Jejunojejunal Bypass (SGJB) instead of RYGB.
References
Raffaelli M, Sessa L, Mingrone G, et al. Assessing the obese diabetic patient for bariatric surgery: which candidate do I choose? Diabetes Metab Syndr Obes. 2015;8:255–62.
Hopkins JC, Welbourn R. Long-term outcomes of obesity surgery and implications for health system planning. Curr Obes Rep. 2015;4(3):330–6.
Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27(9):2279–89.
Lin S, Guan W, Yang N, et al. Short-term outcomes of sleeve gastrectomy plus jejunojejunal bypass: a retrospective comparative study with sleeve Gastrectomy and roux-en-Y gastric bypass in Chinese patients with BMI ≥35 kg/m(2). Obes Surg. 2019;29(4):1352–9.
Obeid NR, Malick W, Concors SJ, et al. Long-term outcomes after roux-en-Y gastric bypass: 10- to 13-year data. Surg Obes Relat Dis. 2016;12(1):11–20.
Raijman I, Strother SV, Donegan WL. Gastric cancer after gastric bypass for obesity. Case report J Clin Gastroenterol. 1991;13(2):191–4.
Harper JL, Beech D, Tichansky DS, et al. Cancer in the bypassed stomach presenting early after gastric bypass. Obes Surg. 2007;17(9):1268–71.
Corsini DA, Simoneti CA, Moreira G, et al. Cancer in the excluded stomach 4 years after gastric bypass. Obes Surg. 2006;16(7):932–4.
Escalona A, Guzman S, Ibanez L, et al. Gastric cancer after roux-en-Y gastric bypass. Obes Surg. 2005;15(3):423–7.
Tinoco A, Gottardi LF, Boechat ED. Gastric Cancer in the excluded stomach 10 years after gastric bypass. Case Rep Surg. 2015;2015:468293.
Tornese S, Aiolfi A, Bonitta G, et al. Remnant gastric Cancer after roux-en-Y gastric bypass: narrative review of the literature. Obes Surg. 2019;29(8):2609–13.
Thorban S, Bottcher K, Etter M, et al. Prognostic factors in gastric stump carcinoma. Ann Surg. 2000;231(2):188–94.
Takeno S, Hashimoto T, Maki K, et al. Gastric cancer arising from the remnant stomach after distal gastrectomy: a review. World J Gastroenterol. 2014;20(38):13734–40.
Ohira M, Toyokawa T, Sakurai K, et al. Current status in remnant gastric cancer after distal gastrectomy. World J Gastroenterol. 2016;22(8):2424–33.
Orlando G, Pilone V, Vitiello A, et al. Gastric cancer following bariatric surgery: a review. Surg Laparosc Endosc Percutan Tech. 2014;24(5):400–5.
Sundbom M, Hedenstrom H, Gustavsson S. Duodenogastric bile reflux after gastric bypass: a cholescintigraphic study. Dig Dis Sci. 2002;47(8):1891–6.
Csendes A, Smok G, Burgos AM, et al. Prospective sequential endoscopic and histologic studies of the gastric pouch in 130 morbidly obese patients submitted to roux-en-Y gastric bypass. Arq Bras Cir Dig. 2012;25(4):245–9.
Sinning C, Schaefer N, Standop J, et al. Gastric stump carcinoma - epidemiology and current concepts in pathogenesis and treatment. Eur J Surg Oncol. 2007;33(2):133–9.
Paduraru DN, Nica A, Ion D, et al. Considerations on risk factors correlated to the occurrence of gastric stump cancer. J Med Life. 2016;9(2):130–6.
Sepulveda M, Alamo M, Preiss Y, et al. Metabolic surgery comparing sleeve gastrectomy with jejunal bypass and roux-en-Y gastric bypass in type 2 diabetic patients after 3 years. Obes Surg. 2018;28(11):3466–73.
Alamo M, Sepulveda M, Gellona J, et al. Sleeve gastrectomy with jejunal bypass for the treatment of type 2 diabetes mellitus in patients with body mass index <35 kg/m2. A cohort study. Obes Surg. 2012;22(7):1097–103.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Statement of informed consent
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Chen, W., Zhang, G., Dong, Z. et al. Cardia Gastric Cancer in the Gastric Pouch 5 Years after Gastric Bypass: A Case Report. OBES SURG 30, 2021–2025 (2020). https://doi.org/10.1007/s11695-019-04336-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-019-04336-y